+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Respiratory Failure Drug"

Acute Respiratory Failure Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players - Product Thumbnail Image

Acute Respiratory Failure Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

  • Report
  • May 2022
  • 35 Pages
  • Global
From
  • 1 Results (Page 1 of 1)
Loading Indicator

The Respiratory Failure Drug market is a subset of the larger Respiratory Drugs market. It includes drugs used to treat respiratory failure, a condition in which the lungs are unable to adequately exchange oxygen and carbon dioxide. These drugs are used to improve oxygenation, reduce inflammation, and reduce the risk of infection. Common drugs used to treat respiratory failure include bronchodilators, corticosteroids, antibiotics, and mucolytics. The Respiratory Failure Drug market is highly competitive, with many companies offering a variety of products. Major players in the market include GlaxoSmithKline, AstraZeneca, Merck, Pfizer, and Novartis. Other companies in the market include Sanofi, Boehringer Ingelheim, and Teva Pharmaceuticals. Show Less Read more